ERBB2 and invasive breast carcinoma: IGF-1R may have differential prognostic impact in BrCa molecular subtypes; IGF-1R has been associated with favorable outcome in patients with the luminal B BrCa molecular subtype, in contrast to HER2 enriched patients [74].